Literature DB >> 19239375

Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.

Sheila M Nolan1, Jeffrey S Gerber, Theoklis Zaoutis, Priya Prasad, Susan Rettig, Kimberly Gross, Karin L McGowan, Anne F Reilly, Susan E Coffin.   

Abstract

OBJECTIVE: To detect the burden of vancomycin-resistant Enterococcus (VRE) colonization among pediatric oncology patients and to determine risk factors for VRE acquisition.
DESIGN: Retrospective case-control study.
SETTING: The Children's Hospital of Philadelphia. PATIENTS: Pediatric oncology patients hospitalized from June 2006 through December 2007.
METHODS: Prevalence surveys revealed an increased VRE burden among pediatric oncology patients. For the case-control study, the 16 case patients were pediatric oncology patients who had 1 stool sample negative for VRE at screening before having a stool sample positive for VRE at screening; the 62 control patients had 2 consecutive screenings in which stool samples were negative for VRE. Case and control patients were matched on the duration of the interval between screens. Analyses were performed to determine the association between multiple exposures and VRE acquisition.
RESULTS: The prevalence survey revealed that 5 (9.6%) of 52 patients had unsuspected VRE colonization at the time of hospitalization. Multivariate analysis identified a lack of empirical contact precautions (odds ratio [OR], 17.16 [95% confidence interval {CI}, 1.49-198.21]; P= .02) and the presence of a gastrointestinal device (OR, 4.03 [95% CI, 1.04-15.56]; P= .04) as significant risk factors for acquisition of VRE. Observations in the interventional radiology department revealed that staff could not access the portions of the electronic medical record in which isolation precautions were documented. Simple interventions that granted access and that trained interventional radiology staff to review the need for precautions, coupled with enhanced infection control practices, interrupted ongoing transmission and reduced the proportion of VRE screens that were positive to 15 (1.2%) of 1,270.
CONCLUSIONS: Inadequate communication with regard to infection control precautions can increase the risk of transmission of epidemiologically important organisms, particularly when patients receive care at multiple clinic locations. Adherence to infection control practices across the spectrum of care may limit the spread of resistant organisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239375      PMCID: PMC2900794          DOI: 10.1086/596202

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  27 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic.

Authors:  Gert Jan Timmers; Wil C van der Zwet; Ina M Simoons-Smit; Paul H M Savelkoul; Helena H M Meester; Christina M J E Vandenbroucke-Grauls; Peter C Huijgens
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

3.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.

Authors:  M J Bonten; S Slaughter; A W Ambergen; M K Hayden; J van Voorhis; C Nathan; R A Weinstein
Journal:  Arch Intern Med       Date:  1998-05-25

4.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

Authors:  K J Henning; H Delencastre; J Eagan; N Boone; A Brown; M Chung; N Wollner; D Armstrong
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

5.  Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center.

Authors:  H Hanna; J Umphrey; J Tarrand; M Mendoza; I Raad
Journal:  Infect Control Hosp Epidemiol       Date:  2001-04       Impact factor: 3.254

6.  Control of vancomycin-resistant enterococcus in health care facilities in a region.

Authors:  B E Ostrowsky; W E Trick; A H Sohn; S B Quirk; S Holt; L A Carson; B C Hill; M J Arduino; M J Kuehnert; W R Jarvis
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.

Authors:  L S Chavers; S A Moser; E Funkhouser; W H Benjamin; P Chavers; A M Stamm; K B Waites
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

8.  Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.

Authors:  I Raad; R Hachem; H Hanna; P Bahna; I Chatzinikolaou; X Fang; Y Jiang; R F Chemaly; K Rolston
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

9.  Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.

Authors:  E M Mascini; A Troelstra; M Beitsma; H E M Blok; K P Jalink; T E M Hopmans; A C Fluit; R J Hene; R J L Willems; J Verhoef; M J M Bonten
Journal:  Clin Infect Dis       Date:  2006-02-10       Impact factor: 9.079

10.  Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus.

Authors:  Yehuda Carmeli; George M Eliopoulos; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more
  6 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions.

Authors:  Erica Co-Reyes; Rhea Li; Winston Huh; Joya Chandra
Journal:  Pediatr Blood Cancer       Date:  2012-09-04       Impact factor: 3.167

Review 3.  Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.

Authors:  Nico T Mutters; Volker Mersch-Sundermann; Reinier Mutters; Christian Brandt; Wulf Schneider-Brachert; Uwe Frank
Journal:  Dtsch Arztebl Int       Date:  2013-10-25       Impact factor: 5.594

4.  Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region.

Authors:  V C C Cheng; J F W Chan; J W M Tai; Y Y Ho; I W S Li; K K W To; P L Ho; K Y Yuen
Journal:  Emerg Health Threats J       Date:  2010-03-31

5.  Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review.

Authors:  Nikos Ulrich; Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Heliyon       Date:  2017-12-28

Review 6.  Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments.

Authors:  Nikos Ulrich; Petra Gastmeier
Journal:  GMS Hyg Infect Control       Date:  2017-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.